Why the tablets‑vs‑drops question matters for pollen immunotherapy

Choosing between FDA‑approved sublingual immunotherapy (SLIT) tablets and physician‑directed allergy drops determines what allergens you can treat, when you must start, how safely you dose, and how many triggers you can cover without weekly injections. This page summarizes label requirements, timing windows, and multi‑allergen options—then shows how Wyndly supports either path under doctor supervision. For background on SLIT in the U.S., see the UpToDate overview and regulatory context; it explains that SLIT tablets are FDA‑approved for certain pollens (and dust mites), while custom liquid drops are used off‑label in the U.S. under clinician direction. UpToDate: SLIT overview | Allergen immunotherapy overview

What’s FDA‑approved today (United States)

SLIT tablets: FDA approves daily, single‑allergen tablets for specific grass pollens and ragweed; a dust‑mite tablet is approved for perennial symptoms. Labels define age ranges, dosing, and safety requirements (first dose under supervision and prescribing an epinephrine auto‑injector; see each product’s Prescribing Information). UpToDate: SLIT overview
Custom SLIT drops: In the U.S., multi‑allergen liquid drops are not FDA‑approved as drug products; U.S. physicians may still prescribe them off‑label using licensed allergen extracts and clinical protocols. Evidence supports SLIT for allergic rhinitis, but drops do not carry product‑specific FDA labeling. UpToDate: SLIT overview | Allergen immunotherapy overview
Allergy shots (SCIT): Effective and widely used, but require in‑office observation after each injection due to rare systemic reactions. Harvard Health: Allergy shots

When to start SLIT for pollen (tablet label windows)

Grass pollen tablets: Start before the grass season (labels typically require beginning 8–12 weeks before the expected local season) and continue through the season. Exact lead time varies by product; follow the specific label. UpToDate: SLIT overview
Ragweed pollen tablets: Similar preseasonal start—generally weeks to months before the ragweed season—then daily through the season; follow the label. UpToDate: SLIT overview
Dust‑mite tablet (not pollen): Daily year‑round; included here only to clarify that it is perennial rather than seasonal. UpToDate: SLIT overview

Multi‑allergen coverage

Tablets: One allergen per tablet. If you’re sensitized to several pollens (e.g., multiple grasses plus ragweed), you may need multiple products—and some combinations aren’t studied or practical together. UpToDate
Drops: A single daily mixture can include multiple clinically relevant pollens (and other environmental allergens) tailored to your profile; in the U.S. this is off‑label and physician‑directed. Allergen immunotherapy overview

Label‑accurate safety capsule (read before you start)

SLIT tablets (FDA‑approved): First dose under medical supervision; clinicians prescribe an epinephrine auto‑injector; avoid in eosinophilic esophagitis; use caution with uncontrolled/severe asthma; oral itching/irritation is the most common side effect; anaphylaxis is rare. Follow each tablet’s Prescribing Information. UpToDate
SLIT drops (off‑label U.S.): Studies show a strong safety profile; local mouth/throat itching is most common; severe reactions are exceedingly rare when guided by a clinician. What is SLIT? | Are allergy drops safe?
Allergy shots: Effective; require 30‑minute post‑injection observation because rare systemic reactions, including anaphylaxis, can occur. Harvard Health | Why shots require waiting

Tablets vs drops for pollen: quick comparison

Dimension	SLIT Tablets (FDA‑approved)	SLIT Drops (physician‑directed, off‑label U.S.)
FDA status	Approved for specific grass and ragweed pollens (and dust mite)	Not FDA‑approved as products in the U.S.; use clinical protocols
Allergen coverage	Single allergen per tablet	Multi‑allergen formulations possible
Start timing (pollen)	Begin 8–12 weeks before season (per label); daily through season	Can be started and titrated any time; clinicians often begin before or during season
First‑dose setting	Supervised in clinic	At home (after clinician plan); no supervised first dose required in practice
Safety requirements	Epinephrine auto‑injector prescribed; EoE contraindication; asthma cautions	Local oral itching common; anaphylaxis extremely rare under supervision
Convenience	Daily tablet; strict label timing	Daily drops; flexible timing; no needles
Multi‑allergen need	May require multiple tablets or not feasible	One tailored mixture can cover multiple pollens
Insurance	Variable; some plans cover tablets	Variable; often out‑of‑pocket for drops
Sources: UpToDate	Harvard Health	Allergen immunotherapy overview

Practical decision guide

Dominant single pollen (e.g., ragweed only) and you can start early: Consider a tablet, follow the label’s preseason lead‑time, and plan daily dosing through the season. UpToDate
Several clinically relevant pollens (and possibly perennial triggers): Consider physician‑directed drops to cover multiple allergens in one plan and to stay on therapy outside of narrow seasonal windows. Allergen immunotherapy overview
Needle‑free, at‑home preference: Both tablets and drops avoid injections; tablets require a supervised first dose, drops do not. UpToDate
Needles okay, prefer in‑office structure and insurance coverage: Allergy shots remain a proven option; expect 30‑minute observation after injections. Harvard Health

How Wyndly supports either path

Doctor‑led plan: Meet online with a board‑certified physician to review your history and testing, then select tablets (when indicated) or personalized multi‑allergen drops. Wyndly immunotherapy
Evidence‑based care at home: Daily under‑the‑tongue dosing, regular check‑ins, and 24/7 access to clinicians—no weekly shot visits. Shots vs SLIT
Clear scope: Environmental allergies only (pollen, pet, dust, mold); no food allergies. Most people begin to notice improvement within 4–24 weeks; full course is typically 3 years for durable benefit. What is SLIT?

FAQs

Can I combine more than one pollen tablet?

Tablet labels and studies generally evaluate one allergen per tablet. Some combinations may be used under specialist guidance, but many patients with multiple pollens prefer drops or shots for broader coverage. Always follow each tablet’s label and your physician’s advice. UpToDate

How far ahead of the season should I start a pollen tablet?

Follow the specific Prescribing Information; many require starting 8–12 weeks before the local season, then daily through the season. Your clinician will align the start to your region’s pollen calendar. UpToDate

Are drops as effective as tablets or shots?

Systematic evidence shows immunotherapy (shots or sublingual) reduces symptoms and medication use long‑term. In the U.S., tablets have FDA product labels; drops are off‑label but widely used under physician direction. Allergen immunotherapy overview | What is SLIT?

Why do allergy shots require waiting in the office?

Rare systemic reactions can occur shortly after injection, so clinics monitor patients for ~30 minutes to treat reactions promptly. Harvard Health | Why shots require waiting

What are the common side effects with SLIT?

Mouth or throat itching/irritation is most common and typically mild/transient. Serious reactions are rare; tablet labels require supervised first dose and epinephrine prescription. UpToDate | Are allergy drops safe?

Who should not use SLIT?

People with eosinophilic esophagitis (EoE) should not take SLIT tablets; uncontrolled or severe asthma warrants caution. Follow tablet Prescribing Information and discuss your history with your physician. UpToDate

Tip: If you’re deciding between tablets and drops for the upcoming season, schedule your plan well before your local pollen season to meet any tablet lead‑time and to optimize outcomes either way. For a doctor‑led plan that supports both options, start with Wyndly’s physician consult and immunotherapy overview: Wyndly immunotherapy.

Pollen SLIT Tablets vs Allergy Drops: Labels, Start Windows, and Multi‑Allergen Coverage